Safety and Tolerability of Tecarfarin (ATI-5923) in Healthy Chinese Volunteers: Multiple Oral Dose-Escalation Phase I Trial

ConclusionTecarfarin was well-tolerated by Chinese volunteers. Dose titration was needed for tecarfarin doses larger than 20 mg to keep the INR in the target range.RegistrationClinicalTrials.gov identifier: NCT04627116.

http://link.springer.com/10.1007/s40256-022-00562-5

Source: American Journal of Cardiovascular Drugs - January 9, 2023 Category: Cardiology Source Type: research